Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
11/2005
11/09/2005EP1592313A1 Infant formula supplemented with phospholipids
11/09/2005EP1519740A4 Rapid improvement of cognition in conditions related to a-beta
11/09/2005EP1511726B1 Method for preparing 1,3,5-triaminobenzene and hydrolyzing it into high-purity phloroglucinol
11/09/2005EP1501787B1 N-biphenylmethyl aminocycloalkanecarboxamide derivatives with a substiituent on the methyl useful as bradykinin antagonists
11/09/2005EP1480983B1 Heteroaryl substituted 2-pyridinyl and 2-pyrimidinyl-6,7,8,9-tetrahydropydimido[1,2-a]pyrimidin-4-one derivatives
11/09/2005EP1480981B1 1-(alkyl), 1-(heteroaryl)alkyl and 1-[(aryl)alkyl]-7-(pyrimidin-4-yl)-imidazo[1,2-a]pyrimidin-5(1h)-one derivatives
11/09/2005EP1476433B1 Novel tricycloimidazoline derivatives, method for production and use thereof as medicaments
11/09/2005EP1456202B1 Benzothiazoles
11/09/2005EP1409531B1 Heterocarpine, a human ghrh-binding protein
11/09/2005EP1405083B1 Natural ligand of gpcr chemr23 and uses thereof
11/09/2005EP1365748B1 Particulate composition of eletriptan hydrobromide showing a sigmoidal pattern of controlled release
11/09/2005EP1315714B1 Quinazoline derivatives as alpha-1 adrenergic antagonists
11/09/2005EP1313700B1 10-aryl-11h-benzo[b]fluorene derivatives and analogs as estrogenic compounds
11/09/2005EP1287142B1 Nucleic acid molecule comprising a nucleic acid sequence coding for an sdf-1 gamma chemokine, a neuropeptide precursor or at least one neuropeptide
11/09/2005EP1278729B1 Benzosuberonylpiperidine compounds as analgesics
11/09/2005EP1259514B9 3-(pyrolyllactone)-2-indolinone compounds as kinase inhibitors
11/09/2005EP1254118B1 Substituted 1,2,3,4- tetrahydroquinoline-2-carboxylic acid derivatives
11/09/2005EP1246930B1 Replication incompetent herpes virus vectors
11/09/2005EP1220932B1 Human carboxypeptidases and polynucleotides encoding the same
11/09/2005EP1214325B1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPases)
11/09/2005EP1212421B1 Gas1 polypeptides
11/09/2005EP1212296B1 Phosphate mimics and methods of treatment using phosphatase inhibitors
11/09/2005EP1204669B1 Tricyclic monosaccharide derivatives useful in treating acute ischemia-induced neurodegeneration
11/09/2005EP1202974B1 Pyrimidine-2,4,6-trione metalloproteinase inhibitors
11/09/2005EP1196403B1 Antipsychotic cyclic n-aralkyl amines
11/09/2005EP1189605B1 High molecular weight primary aliphatic alcohols obtained from beeswax and pharmaceutical use thereof
11/09/2005EP1163236B1 Aromatic heterocyclic compounds as anti-inflammatory agents
11/09/2005EP1144371B1 Benzenesulphonamide derivatives and their use as mek inhibitors
11/09/2005EP1095016B1 Sulfur substituted sulfonylaminocarboxylic acid n-arylamides, their preparation, their use and pharmaceutical preparations comprising them
11/09/2005EP1049700B1 Chemokine receptor antagonists and methods of use therefor
11/09/2005EP1042275B1 Anticonvulsant and central nervous system-active bis(fluorophenyl)alkylamides
11/09/2005EP0929521B1 Nmda (n-methyl-d-aspartate) antagonists
11/09/2005CN1694900A EE3-protein family and corresponding DNA sequences
11/09/2005CN1694883A Hydroxy alkyl substituted 1,3,8-triazaspiro[4.5]decan-4-one derivatives useful for the treatment of orl-1receptor mediated disorders
11/09/2005CN1694875A 5-aryltetrazole compounds and uses thereof
11/09/2005CN1694864A N-bridged selective androgen receptor modulators and methods of use thereof
11/09/2005CN1694702A Neurotrophic factor production promoter
11/09/2005CN1694701A Methods for treating disorders associated with mGLU receptors including addiction and depression
11/09/2005CN1694694A Eicosapentaenoic acid (EPA) for treating anorexia nervosa (AN) and bulimia
11/09/2005CN1226299C Fatty alcohol glycoside compound-acanthus ilicifolius glycoside C and its application
11/09/2005CN1226045C Medicine for treating headache
11/09/2005CN1226036C New therapeutic combinations of mirtazapine and antipsychotic agents, for treatment of prophylaxis of psychotic disorders
11/09/2005CN1226035C New use of iloperidone
11/08/2005US6963011 Central nervous system disorders; psychological disorders
11/08/2005US6963010 Hydrophobic polyamine analogs and methods for their use
11/08/2005US6963000 Benzothiazole derivatives with activity as adenosine receptor ligands
11/08/2005US6962996 Inhibitors of p38
11/08/2005US6962993 Useful as inhibitors of protein kinases, such as the enzyme Janus Kinase 3
11/08/2005US6962969 Compounds and methods for modulating nonclassical cadherin-mediated functions
11/08/2005US6962941 such as 1,4-Bis-{N-[3-(3-aminomethylphenylproplonyl)-2-methoxycarbonylpyrrolidin-4-yl]aminocarbonyloxy}-2-butyne dihydrochloride; for treatment of asthma, allergic conjunctivitis, allergic rhinitis, psoriasis, and ulcerative colitis
11/08/2005US6962940 Controrlling concentration of tumor necrosis factor, phosphodiesterase inhibitor; controlling cell differentiation, proliferation; antiinflammatory agents; cardiovascular disorders
11/08/2005US6962939 Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands
11/08/2005US6962937 Imidazolidine derivatives, their preparation and their use
11/08/2005US6962936 Treating diseases such as cancer, inflammatory disorders, restenosis,
11/08/2005US6962934 Such as N-((2S)-2-((3-((dipropylamino)carbonyl)-benzoyl) amino)-3-phenylpropyl)-L-alanyl-N1-isobutyl-L-valinamide; secretase inhibitors
11/08/2005US6962933 cerebral hemorrhage/infarction, head trauma, spinal cord injury, brain edema, multiple sclerosis, Alzheimer's/Parkinson's disease, amyotrophic lateral sclerosis, diabetes, osteoporosis, Creutzfeldt-Jakob disease or virus infections
11/08/2005US6962930 such as N,N-diphenyl)-4-ureido-5,7-dichloro-2-carboxyquinolinefor treatment of drug abuse/dependence; side effects reduction
11/08/2005US6962921 Dementia remedies containing 2-aryl-8-oxodihydropurine derivatives as the active ingredient
11/08/2005US6962918 Hexahydropyrazino[1'2';1,6]pyrido[3,4-b]indole-1,4-diones for the treatment of cardiovascular disorders and erectile dysfunction
11/08/2005US6962915 Antiinflammatory agents
11/08/2005US6962908 Oral pharmaceutical products containing 17 β-estradiol-3-lower alkanoate, method of administering the same and process of preparation
11/08/2005US6962907 such as 3-(aminocyclopentanyl)butylphosphinic acid ; GABA (gamma-amino-butyric acid) receptor agonists/antagonists; for memory enhancement
11/08/2005US6962799 Microtubule-associated proteins and tubulins
11/08/2005US6962717 Pharmaceutical compositions
11/08/2005US6962703 Clostridial toxin derivatives able to modify peripheral sensory afferent functions
11/08/2005CA2319272C Novel aminoalkanesulphonic, -phosphonic and -phosphinic acid derivatives, their preparation and their use as medicaments
11/08/2005CA2310950C An efficacious dosage regiment of galantamine that reduces side effects
11/08/2005CA2251690C New indications for the use as medicaments of multipotent parapox immunity inducers from attenuated, non-immunogenic pox viruses or parapox viruses
11/03/2005WO2005103713A2 Methods, compositions and compound assays for inhibiting amyloid-beta protein production
11/03/2005WO2005103291A1 Novel ligand of g-protein-conjugated receptor protein and use thereof
11/03/2005WO2005103288A1 Screening method
11/03/2005WO2005103089A1 Fish-origin chondroitin sulfate/dermatan sulfate hybrid chain
11/03/2005WO2005103037A2 Selected cgrp antagonists, methods for the production thereof, and use thereof as medicaments
11/03/2005WO2005103012A1 Hydrazino-substituted heterocyclic nitrile compounds and use thereof
11/03/2005WO2005103011A1 Processes for preparing substituted n-aryl-n’-[3-(1h-pyrazol-5-yl) phenyl] ureas and intermediates thereof
11/03/2005WO2005102370A1 Chinese medicine for stopping drug addiction
11/03/2005WO2005102365A1 Neurotransmission switching material
11/03/2005WO2005102321A1 Composition for acceleration of alcohol metabolism or recuperation from fatigue through gluconeogenesis
11/03/2005WO2005102316A2 Use of coumarin derivatives
11/03/2005WO2005102314A1 The use of butylphthalide homologues in preparing the drug of preventing and treating cerebral ischemic
11/03/2005WO2005002555A3 Sirt1 modulators for manipulating cell/organism lifespan/stress response
11/03/2005WO2004087073A3 Treatment of demyelinating conditions
11/03/2005WO2004064811A8 A composition material for transmucosal delivery
11/03/2005WO2003068168A3 Helical peptidomimetics and use b-amyloid-associated diseases
11/03/2005US20050245750 Process for preparing 1,3-benzodioxole-2-spirocycloalkane derivative
11/03/2005US20050245743 depression and/or anxiety, obesity, urinary disorder; 5-(2-Methoxyphenyl)-N-[3-(4-Piperidinyl)Phenyl]Pentanamide
11/03/2005US20050245741 Novel tricyclic spiropiperidines or spiropyrrolidines
11/03/2005US20050245611 Administering intravenous valproate such that acute migraine headache is lessened or reduced in subject, wherein about 250 mg to 750 mg of valproate is administered to a subject over 30 minutes to 1 hour
11/03/2005US20050245602 Selective estrogen receptor modulators
11/03/2005US20050245595 Positive modulators of nicotinic receptor agonists
11/03/2005US20050245592 2-Iminopyrrolidine derivatives
11/03/2005US20050245587 Treatment of dyskinesia
11/03/2005US20050245586 2,5-Dioxoimidazolidin-4-yl acetamides and analogues as inhibitors of metalloproteinase mmp12
11/03/2005US20050245581 3-(2-Cyanophenyl)-5-(2-methoxyphenyl)-1-phenyl-1,2-dihydropyridin-2-one; antagonists of AMPA and kainate receptors; neuroprotectants; neurodegenerative diseases; Alzheinmer's disease; antiepileptic agents; antispasmodic agents; anxiolytic agents; ddrug abuse; nervous sytem disorders; antihypoxic agents
11/03/2005US20050245575 1-((5-aryl-1,2,4-oxadiazol-3-yl) benzyl)azetidine-3-carboxylates and 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl) pyrrolidine-3-carboxylates as edg receptor agonists
11/03/2005US20050245574 Aminophenoxyacetic acid derivatives and pharmaceutical composition containing thereof
11/03/2005US20050245572 Naphthyl ether compounds and their use
11/03/2005US20050245567 Novel quinuclidine derivatives and their use
11/03/2005US20050245556 Pharmaceutical preparation containing oxycodone and naloxone
11/03/2005US20050245554 Substituted pyrimidines
1 ... 928 929 930 931 932 933 934 935 936 937 938 939 940 941 942 943 944 945 946 947 948 ... 1833